4Basebio PLC banner

Cash Flow Statement

Cash Flow Statement
4Basebio PLC

Rotate your device to view
Cash Flow Statement
Currency: GBP
Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024 Dec-2024 Jun-2025
Operating Cash Flow
Net Income
(3)
(4)
(5)
(6)
(8)
(10)
(12)
(14)
Depreciation & Amortization
0
0
0
1
1
1
1
1
Stock-Based Compensation
0
0
0
0
0
0
0
0
Other Non-Cash Items
(0)
(0)
(1)
(0)
(0)
0
0
(0)
Cash Taxes Paid
0
0
(0)
(1)
(1)
(0)
(0)
(0)
Cash Interest Paid
0
0
0
0
0
0
0
0
Change in Working Capital
0
0
1
1
1
0
1
(0)
Cash from Operating Activities
(3)
N/A
(4)
-29%
(5)
-33%
(5)
-11%
(6)
-18%
(8)
-35%
(11)
-29%
(14)
-28%
Investing Cash Flow
Capital Expenditures
(2)
(3)
(2)
(1)
(1)
(1)
(2)
(2)
Other Items
0
0
0
0
0
0
0
0
Cash from Investing Activities
(2)
N/A
(3)
-66%
(2)
+23%
(1)
+33%
(1)
-14%
(1)
+3%
(2)
-8%
(2)
+3%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
0
1
39
38
Net Issuance of Debt
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Other
(0)
(0)
1
5
7
8
5
0
Cash from Financing Activities
(0)
N/A
(0)
+22%
1
N/A
5
+277%
6
+37%
9
+37%
44
+398%
39
-12%
Change in Cash
Effect of Foreign Exchange Rates
(1)
(1)
0
(0)
(0)
0
(0)
0
Net Change in Cash
(5)
N/A
(7)
-28%
(5)
+25%
(2)
+61%
(1)
+37%
(1)
+34%
32
N/A
23
-26%
Free Cash Flow
Free Cash Flow
(4)
N/A
(6)
-42%
(7)
-10%
(7)
+2%
(8)
-17%
(10)
-28%
(12)
-26%
(15)
-24%